Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression;Correlazioni tra modificazioni radiografiche, ecografiche e RMN e progressione dell'artrite reumatoide

Reumatismo

Volumn 56, Issue 1 SUPPL. 1, 2004, Pages 28-40

  Cimmino, Marco A ^a,b   Parodi, M ^a   Silvestri, E ^b   Garlaschi, G ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Echography; Magnetic resonance imaging; Radiology; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; CYCLOSPORIN; ETANERCEPT; GOLD SALT; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SULFALAZINE;

CORRELATION FUNCTION; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 2342486621     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Scott DL, Laasonen L, Priolo F, Houssien DA, Bacarini L, Cerase E, Cammisa M. The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 1997; 15: S53-61.
2. Garlaschi M, Silvestri E, Satragno L, Cimmino MA. The rheumatoid hand: diagnostic imaging. Springer-Verlag, Milano 2002.
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
4. Molenaar ET, Boers M, van der Heijde DM, Alarcon G, Bresnihan B, Cardiel M, et al. Imaging in rheumatoid arthritis: results of group discussions. J Rheumatol 1999; 26: 749-51.
5. Berens DL, Lockie LM, Lin RK, Norcross BM. Roentgen changes in early rheumatoid arthritis: wrists-hands-feet. Radiology 1964; 82: 645-53.
6. Green MJ, Deodhar AA. Bone changes in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001; 15: 105-23.
7. Solymossy C, Dixey J, Utley M, Gallivan S, Young A, Cox N, et al. Larsen scoring of digitized X-ray images. Rheumatology (Oxford) 1999; 38: 1127-9.
8. Ferraccioli GF, Salaffi F, Manganelli P. Need for acceptable measures of disease progression in rheumatoid arthritis. Lancet 1987; 2: 388-9.
9. Salaffi F, Carotti M, Lamanna G, Baldelli S. L'analisi quantitativa della progressione radiologica nell'artrite reumatoide: controversie e prospettive. Radiol Med 1997; 93: 174-84.
10. Steinbrocker O, Traeger GH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
11. Kellgren JH, Lawrence JS. Radiological assessment of rheumatoid arthritis. Ann Rheum Dis 1957; 16: 485-93.
12. Trentham DE, Masi AT. Carpo/metacarpal ratio. A new quantitative measure of radiologic progression of wrist involvement in rheumatoid arthritis. Arthritis Rheum 1976; 19: 939-44.
13. Larsen A. Radiological grading of rheumatoid arthritis: an interobserver study. Scand J Rheumatol 1973; 2: 136-41.
14. Sharp JT, Litsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiological changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratori abnormalities. Arthritis Rheum 1971; 14: 706-20.
15. Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol 1998; 25: 417-26.
16. Kaarela K, Kautiainen H. Continuous progression of radiological destruction in seropositive rheumatoid arthitis. J Rheumatol 1997; 24: 1285-7.
17. Belghomari H, Saraux A, Allain J, Guedes C, Youinou P, Le Goff P. Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis. J Rheumatol 1999; 26: 2534-8.
18. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, et al. Evidence from clinical trias and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology 2002; 41: 1346-56.
19. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 347-56.
20. Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Fin-RACo trial group. Lancet 1999; 353: 1568-73.
21. Strand V, Landéwé R, van der Heijde D. Using estimated yearly progression rates to comapre radiographic data across recent randomised controlled trials in rheumatoid arthritis. Ann Rheum Dis 2002; 61 (suppl II): ii64-ii66.
22. Lipsky PE, van der Heijde DMFM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. New Eng J Med 2000; 343: 1594-602.
23. Van der Heijde D. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 1996; 10: 435-43.
24. Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002; 46: 1443-50.
25. den Broeder AA, Joosten LA, Saxne T, Heinegard D, Fenner H, Miltenburg AM, et al. Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis 2002; 61: 311-8.
26. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljian Z, Emery P, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41: 2196-204.
27. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. A multicenter, double-blind, dose-ranging, randomised, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000; 43: 1001-9.
28. Grassi W, Cervini C. Ultrasonography in rheumatology: an evolving technique. Ann Rheum Dis 1998; 57: 268-71.
29. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 2762-70.
30. Silvestri E, Martinoli C, Onetto F, Neumaier CE, Cimmino MA, Derchi LE. Valutazione dell'artrite reumatoide del ginocchio con color Doppler. Radiol Med 1994; 88: 364-7.
31. Carotti M, Salaffi F, Manganelli P, Salera D, Simonetti B, Grassi W. Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience. Ann Rheum Dis 2002; 61: 877-82.
32. Cimmino MA, Bountis C, Garlaschi G, Silvestri E, Accardo S. An appraisal of magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Arthritis Rheum 2000; 30: 180-95.
33. Peterfy CG, Roberts T, Genant HK. Dedicated extremity MR imaging. An emerging technque. Radiol Clin North Am 1997; 35: 1-20.
34. Mc Queen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PLJ, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symtom onset. Ann Rheum Dis 1998; 57: 350-6.
35. Cimmino MA, Garlaschi G, Bountis C, Silvestri E, Delucchi S, Frisone G, et al. Reproducibility of magnetic resonance readings of erosions in the rheumatoid wrist [abstract]. Arthritis Rheum 1998; 41: S51.
36. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsøe B, et al. MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval: MRI features to predict bone erosions. Eur Radiol 2002; 12: 1203-10.
37. McGonagle D, Green MJ, Proudman S, Richardson C, Veale D, O'Connor P, et al. The majority of patients with rheumatoid arthritis have erosive disease at presentation when MRI of the dominant hand is employed. Br J Rheumatol 1997; 36 (Suppl 1) (Abstract): 121.
38. Østerggard M, Klarlund M. Importance of timing of post-contrast MRI in rheumatoid arthritis: what happens during the first 60 minutes after IV gadolinium-DT-PA? Ann Rheum Dis 2001; 60: 1050-54.
39. Østerggard M, Stoltenberg M, Gideon P, Sorensen K, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996; 23: 1151-61.
40. Jevtic V, Watt I, Rozman B, Kos-Golja M, Praprotnik S, Logar D, et al. Contrast enhanced GD-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients. Clin Exp Rheumatol 1997; 15: 151-6.
41. Lee J, Lee SK, Suh JS, Yoon M, Song JH, Lee CH. Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis. J Rheumatol 1997; 24: 1303-1308.
42. Sugimoto H, Takeda A, Kano S. Assessment of disease activity in rheumatoid arthritis using magnetic resonance imaging: quantification of pannus volume in the hands. Br J Rheumatol 1998; 37: 854-861.
43. Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis by dynamic enhanced resonance imaging. Arthritis Rheum 2002; 46: 366-72.
44. Østergaard M, Klarlund M, Lassere M, Conaghan P, Peterfy C, McQueen F, et al. Interreader agreement in the assessment of magnetic resonance images of rheumatoid arthritis wrist and finger joints-an international multicenter study. J Rheumatol 2001; 28: 1143-50.
45. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 2003; 48: 955-62.
46. Berens DL, Lin RK. Roentgen diagnosis of rheumatoid arthritis. C Thomas, Springfield, 1969.
47. Genant HK. Methods of assessing radiographic changes in rheumatoid arthritis. Am J Med 1983; 75: 35-47.
48. Kaye JJ, Nance EP, Callahan LF, Carroll FE, Winfield AC, Earthman WJ, et al. Observer variation in quantitative assessment of rheumatoid arthritis. Part II. A simplified scoring system. Invest Radiol 1987; 22: 41-6.
49. Rau R, Herbom G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1995; 22: 1976-82.
50. Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies? J Rheumatol 1995; 22: 1974-5.
51. Foley-Nolan D, Stack JP, Ryan M, Redmond U, Barry C, Ennis J, et al. Magnetic resonance imaging in the assessment of rheumatoid arthritis-a comparison with plain film radiographs. Br J Rheumatol 1991; 30: 101-6.
52. Østergaard M, Gideon P, Sorensen K, Hansen M, Stoltenberg M, Henriksen O, et al. Scoring of synovial membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol 1995; 24: 212-8.
53. Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 196: 647-55.
54. Tonolli-Serabian I, Poet JL, Dufour M, Carasset S, Mattei JP, Roux H. Magnetic resonance imaging of the wrist in rheumatoid arthritis: comparison with other inflammatory joint diseases and control subjects. Clin Rheumatol 1996; 15: 137-42.
55. Lindegaard H, Vallo J, Horslev-Petersen K, Junker P, Ostergaard M. Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset. Ann Rheum Dis 2001; 60: 770-6.